Dexamethasone Suppression Tests in Dogs and Cats

Understanding Dexamethasone Suppression Tests

The dexamethasone suppression test (DST) is a critical diagnostic tool used in veterinary medicine to evaluate adrenal and pituitary function in pets. This test measures how the adrenal glands respond to dexamethasone, a synthetic glucocorticoid medication, by assessing cortisol levels in the blood. When dexamethasone is administered, cortisol levels should decrease in response in healthy animals. However, in pets with Cushing’s syndrome (hyperadrenocorticism), this suppression may not occur or may be incomplete, helping veterinarians identify abnormal cortisol production.

Dexamethasone suppression tests play a vital role in identifying one of the most common endocrine disorders in older dogs and cats. Understanding how these tests work, their procedures, and how to interpret results is essential for pet owners whose animals may be showing signs of excessive cortisol production.

What is Cushing’s Syndrome?

Cushing’s syndrome, also known as hyperadrenocorticism, is an endocrine disorder characterized by excessive production of cortisol by the adrenal glands. This condition can develop from three primary causes: pituitary-dependent hyperadrenocorticism (most common), adrenocortical tumors, or iatrogenic Cushing’s syndrome from prolonged corticosteroid medication use.

Affected pets often display clinical signs including increased thirst and urination, increased appetite, hair loss, skin infections, and a characteristic pot-bellied appearance due to abdominal muscle weakness. Cushing’s syndrome typically affects middle-aged to older dogs and cats, and early detection through diagnostic testing like the DST can lead to better management outcomes.

Types of Dexamethasone Suppression Tests

Two primary types of dexamethasone suppression tests are used in veterinary medicine to diagnose and differentiate forms of Cushing’s syndrome:

Low-Dose Dexamethasone Suppression Test (LDDST)

The low-dose dexamethasone suppression test is considered the preferred screening test for initial diagnosis of Cushing’s syndrome in dogs and cats. This test uses a lower dose of dexamethasone to evaluate whether the hypothalamic-pituitary-adrenal (HPA) axis can be suppressed with minimal steroid administration. The LDDST is highly sensitive, meaning false negatives are uncommon, making it an excellent choice for ruling out Cushing’s syndrome when clinical suspicion exists.

The procedure involves:

– A baseline blood sample collected in a plain red-top tube for serum before dexamethasone administration- Injection of 0.015 mg/kg of dexamethasone intramuscularly or intravenously (either dexamethasone sodium phosphate or Azium can be used)- Collection of additional blood samples at 6 and 8 hours post-injection for cortisol measurement

In healthy animals, cortisol levels should suppress significantly after dexamethasone administration. Pets with Cushing’s syndrome typically show little to no suppression of cortisol levels, helping confirm the diagnosis.

High-Dose Dexamethasone Suppression Test (HDDST)

The high-dose dexamethasone suppression test is used in conjunction with LDDST results to differentiate between pituitary-dependent hyperadrenocorticism and adrenocortical tumors. This test operates on the principle that autonomous ACTH hypersecretion by the pituitary can be suppressed by supraphysiological concentrations of steroids, whereas adrenal tumors producing cortisol independently cannot be suppressed regardless of steroid dose.

The procedure involves:

– A baseline blood sample collected in a plain red-top tube for serum- Injection of 0.1 mg/kg of dexamethasone intramuscularly or intravenously (dexamethasone sodium phosphate is recommended for high-dose tests; if Azium is used intravenously, it must be administered very slowly)- Collection of blood samples at 6 and 8 hours post-injection

Results indicating greater than 50% suppression of cortisol suggest pituitary-dependent disease, while failure to suppress suggests an autonomous adrenal tumor.

Test Procedures and Protocol

Proper preparation and execution of dexamethasone suppression tests is crucial for accurate results. Veterinarians must follow specific protocols to ensure reliable diagnostic information.

Pre-Test Considerations

Before administering a dexamethasone suppression test, veterinarians should evaluate whether certain conditions might interfere with test interpretation. Severe illness, stress, concurrent medical conditions such as diabetes mellitus or renal disease, and certain medications can yield inconclusive results or false positives. When possible, these conditions should be ruled out or stabilized before testing, as they can affect the reliability of cortisol measurements and test interpretation.

Sample Collection

Proper blood sample collection is essential for accurate cortisol measurement. All baseline and post-injection samples should be collected in plain red-top tubes without additives to obtain serum. Samples must be handled carefully to prevent hemolysis, which can interfere with cortisol assays. After collection, samples are typically centrifuged, and serum is transferred to separate non-additive tubes for shipment to diagnostic laboratories capable of performing cortisol measurement.

Administration Considerations

The choice between intravenous and intramuscular dexamethasone administration depends on clinical circumstances and available resources. Both routes are effective, though intravenous administration may provide more predictable absorption. For high-dose dexamethasone sodium phosphate given intravenously, careful slow infusion is important to prevent adverse effects.

Test Interpretation

Interpreting dexamethasone suppression test results requires understanding the expected cortisol response patterns in healthy versus affected animals.

Understanding Normal Results

In healthy animals without Cushing’s syndrome, dexamethasone administration triggers negative feedback inhibition of the HPA axis, resulting in significant suppression of cortisol production. Post-injection cortisol levels typically fall to low values, indicating proper axis function and ruling out hyperadrenocorticism as a diagnostic consideration.

Abnormal Results and Their Significance

The low-dose dexamethasone suppression test is fairly sensitive, meaning false negatives are not common, though false negatives and especially false positives can still occur. When cortisol levels fail to suppress appropriately during the LDDST, Cushing’s syndrome becomes a likely diagnosis. However, veterinarians must rule out other diseases that can cause inappropriate suppression or false positives, including uncontrolled diabetes mellitus, renal disease, hepatic disease, and conditions causing significant stress or systemic illness.

Distinguishing Forms of Cushing’s Syndrome

When the LDDST indicates Cushing’s syndrome, the high-dose dexamethasone suppression test helps determine the underlying cause. Results showing greater than 50% cortisol suppression suggest pituitary-dependent disease (Cushing’s disease), where the tumor is responsive to high-dose glucocorticoid negative feedback. Conversely, failure to suppress with high doses indicates an autonomous adrenocortical tumor, where cortisol production continues regardless of dexamethasone administration.

Limitations and Considerations

While dexamethasone suppression tests are valuable diagnostic tools, they have important limitations that veterinarians and pet owners should understand.

Concurrent Medical Conditions

The accuracy of dexamethasone suppression tests can be compromised by concurrent medical conditions. Pets with uncontrolled diabetes mellitus, systemic infections, renal disease, or hepatic disease may show altered dexamethasone suppression patterns, potentially leading to false positive results. A thorough diagnostic workup including a minimum database of blood work, urinalysis, and physical examination is recommended before interpreting DST results in the context of suspected Cushing’s syndrome.

Medication Effects

Certain medications can interfere with test results. Prolonged or recent corticosteroid administration, whether for treatment of other conditions or incidental exposure, can affect HPA axis function and complicate interpretation. Phenobarbital and other medications that induce hepatic metabolism of dexamethasone can also influence test results.

Clinical Judgment

Dexamethasone suppression tests should always be interpreted in conjunction with the patient’s clinical presentation, physical examination findings, and laboratory values. No single diagnostic test is 100% accurate, and veterinary clinicians must integrate multiple sources of diagnostic information to reach appropriate clinical conclusions.

Clinical Applications

Dexamethasone suppression tests serve multiple important roles in veterinary endocrine diagnostics beyond simple screening.

Initial Diagnosis

The LDDST serves as the screening test of choice for canine hyperadrenocorticism when the dog has no concurrent medical conditions or when only dermatological abnormalities are observed. Cats may also be tested using oral LDDST protocols with alternative discriminators such as the urine cortisol-to-creatinine ratio (UCCR), collected after dexamethasone administration at specific intervals.

Cause Differentiation

When combined with LDDST or ACTH-response test results, the high-dose dexamethasone suppression test effectively differentiates between pituitary-dependent hyperadrenocorticism and adrenocortical tumors, guiding treatment decisions and prognosis discussions with pet owners.

Monitoring Response to Treatment

Dexamethasone suppression tests can be used to monitor response to treatment in pets receiving medication for Cushing’s syndrome, helping veterinarians adjust dosages to achieve therapeutic goals while minimizing medication side effects.

Alternative and Complementary Tests

While dexamethasone suppression tests are primary diagnostic tools, other tests may provide complementary information in evaluating adrenal and pituitary function. The ACTH stimulation test measures adrenal responsiveness to adrenocorticotropic hormone stimulation, providing different diagnostic information than dexamethasone suppression. The urine cortisol-to-creatinine ratio (UCCR) offers a non-invasive screening option, particularly useful in cats. Some cases benefit from imaging studies such as ultrasound or computed tomography to visualize the adrenal glands and assess for tumors. Advanced testing like the dexamethasone-suppressed corticotropin-releasing hormone test may be employed in specialized referral settings for challenging diagnostic cases.

Frequently Asked Questions About Dexamethasone Suppression Tests

Q: Is the dexamethasone suppression test painful for my pet?

A: The test involves standard blood draws and a dexamethasone injection, similar to routine vaccinations. Most pets tolerate the procedure well with minimal discomfort. The main inconvenience is the time commitment for multiple blood collections over 6-8 hours.

Q: How long does it take to get results from a dexamethasone suppression test?

A: Results typically take 3-7 business days depending on the diagnostic laboratory. Some referral laboratories can provide faster turnaround times for rush requests.

Q: Can my pet eat or drink before the dexamethasone suppression test?

A: Fasting before blood collection is generally recommended to ensure accurate baseline cortisol measurements. Your veterinarian will provide specific pre-test instructions for your pet’s appointment.

Q: What should I do if my pet shows signs of Cushing’s syndrome?

A: Schedule an appointment with your veterinarian for a physical examination and discussion of clinical signs. Your veterinarian will determine whether diagnostic testing, including dexamethasone suppression tests, is appropriate for your pet’s situation.

Q: Are there risks associated with dexamethasone suppression testing?

A: The test uses minimal dexamethasone doses that are unlikely to cause adverse effects in most pets. However, pets with severe systemic illness or certain medical conditions should be evaluated carefully before testing. Always discuss any concerns with your veterinarian.

Q: Can dexamethasone suppression tests be performed in cats?

A: Yes, both LDDST and HDDST can be performed in cats. Oral LDDST protocols using the urine cortisol-to-creatinine ratio are particularly useful alternatives in feline patients.

Q: What happens if my pet has a positive dexamethasone suppression test?

A: A positive test indicating Cushing’s syndrome means your veterinarian will likely recommend the high-dose dexamethasone suppression test to determine whether the condition is pituitary-dependent or due to an adrenal tumor, guiding subsequent treatment recommendations.

Similar Articles

Breathing Challenges in Flat-Faced Dogs

Diabetes in Dogs Guide

Nighttime Safety for Outdoor Cats

Managing Resource Guarding in Dogs

Cat Kneading Explained

Adding a Second Dog: Key Decisions

Author

Sneha TeteBeauty & Lifestyle Writer

 

Sneha is a relationships and lifestyle writer with a strong foundation in applied linguistics and certified training in relationship coaching. She brings over five years of writing experience to fluffyaffair,  crafting thoughtful, research-driven content that empowers readers to build healthier relationships, boost emotional well-being, and embrace holistic living.

Read full bio of Sneha Tete